LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Code intelligence
C56.9 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code C56.9.
Elevated code riskView ICD-10 detail
Signal breakdown
4 shown · 4 total in platform
Risk: Elevated
0
Critical
0%
1
High
25%
3
Routine
75%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L38119: MolDX: Next-Generation Sequencing for Solid Tumors — Noridian
Policy LCD-L38119 · Oncology
New billing guidelines for solid tumors effective 02/05/2026.
LCD L38067: MolDX: Next-Generation Sequencing for Solid Tumors — CGS
Policy LCD-L38067 · Oncology
New NGS guidelines may reshape solid tumor testing billing.
LCD L38371: Multimarker Serum Tests Related to Ovarian Cancer Testing — Wellpoint Federal
Policy LCD-L38371 · Oncology
Coverage criteria for multimarker serum ovarian cancer tests (Part A & B).
Audit documentation
Building an audit file that includes C56.9?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription